Project Grant HT94252410609
Award Date
7/1/24
Completion Date
6/30/27
Dollars Obligated
$2.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Jacksonville, FL 32224, USA
Similar Awards
The federal Project Grant award, titled "PATHOGENESIS, DIAGNOSIS, AND TREATMENT OF CARDIOVASCULAR FAILURE IN ACUTE PANCREATITIS", was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $1,665,000.00 award, effective from January 1, 2025 to December 31, 2028, will support advanced biomedical research focused on transforming healthcare for military service members and the general public. The prime awardee, Mayo Clinic...
The Defense Health Agency awarded Mayo Clinic Jacksonville $3,232,027 under the Military Medical Research and Development federal grant program (CFDA 12.420) from September 15, 2023 through September 14, 2027. Through this award, Mayo Clinic will integrate molecular pathology, radiology, and genetics to improve breast cancer risk prediction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform health care for service members...
Mayo Clinic was awarded a $8,966,819 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2027 to further develop purified exosome products for treating pulmonary damage from toxic exposures, leveraging Mayo Clinic's expertise in exosome applications. Through this funding, Mayo Clinic aims to advance biomedical solutions applicable to both military and civilian...
The Department of Defense's Defense Health Agency awarded a $322,800 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Mayo Clinic in Rochester, Minnesota. The grant, with a performance period from April 1, 2024 to March 31, 2026, supports research on "MYELOPEROXIDASE PROMOTES PERSISTENT FIBROSIS." As a renowned non-profit academic medical center, Mayo Clinic will leverage its expertise in clinical care, biomedical research, and medical...
The federal Project Grant award of $1,782,155.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research by Mayo Clinic to identify novel drug targets for lethal prostate cancer using liquid biopsy. The award, effective from April 1, 2025, to March 31, 2028, will enable Mayo Clinic to conduct advanced biomedical research focused on transforming healthcare for military service members and the broader public. This...
This federal Project Grant award of $813,085.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at Mayo Clinic Jacksonville to investigate the critical role of PINK1 expression and activity in Parkinson's disease pathophysiology and therapeutic intervention. The grant, awarded on June 1, 2025, with a completion date of May 31, 2028, will enable Mayo Clinic Jacksonville, a non-profit healthcare organization, to...
The U.S. Defense Health Agency has awarded a $1,187,875 Project Grant to Mayo Clinic to support the research project "INVESTIGATING MOLECULAR MECHANISMS UNDERLYING THE CILIARY TRAFFICKING OF POLYCYSTINS". This grant, awarded on April 1, 2024 under the Military Medical Research and Development program (CFDA 12.420), will fund research to advance the understanding of the molecular mechanisms involved in the trafficking of polycystins through cellular cilia. The project aims to yield...
The U.S. Department of Defense's Defense Health Agency awarded a $384,000 Project Grant to the Cold Spring Harbor Laboratory (CSHL) to study the impact of recurrent acute pancreatitis on macrophage heterogeneity and function. This grant, awarded under the Military Medical Research and Development program (CFDA 12.420), will fund research aimed at improving the health and care of military service members, veterans, and their families. The grant has a performance period from February 1, 2024 to...
This $1,971,628 Project Grant awarded by the Defense Health Agency on May 15, 2024 will fund research at the University of Washington to investigate the "Mechanisms of Activin Signaling in Acute Pancreatitis" over a 4-year period ending on May 14, 2028. The research is being conducted under the Military Medical Research and Development program (CFDA 12.420), which supports a range of biomedical research initiatives aimed at improving health outcomes for military service members,...
The federal Project Grant award of $161,400.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support Mayo Clinic's research project titled "AN ATLAS OF THE TUMOR IMMUNE CIRCULOME." This award, with a performance period from June 1, 2024 to May 31, 2025, aims to advance medical knowledge and improve patient care through innovative biomedical research. The Military Medical Research and Development program funds a wide range of...